- Adastra Holdings (XTRX) has signed co-manufacturing agreements to produce pure hydrocarbon-extracted concentrate products
- Adastra is rapidly scaling its production facility to meet the growing demand for hydrocarbon-based products
- CEO Michael Forbes sat down with Shoran Devi to discuss the news
- Adastra is a manufacturer and supplier of innovative ethnobotanical and cannabis science products designed for the adult-use and medical markets
- Adastra Holdings Ltd. (XTRX) opened trading at C$0.81 per share
Adastra Holdings (XTRX) has signed co-manufacturing agreements to produce high-potency, pure hydrocarbon-extracted concentrate products.
These agreements allow Adastra to expand its portfolio of brand partners and brings Adastra closer to exceeding its goal of $5 million per month in sales by summer 2022.
Adastra is also rapidly scaling its production facility to meet the growing demand for hydrocarbon-based products and to capitalize on its recently announced dried flower sales license.
CEO Michael Forbes sat down with Shoran Devi to discuss the news.
Formerly known as Phyto Extractions Inc., Adastra is a leading manufacturer and supplier of innovative ethnobotanical and cannabis science products designed for the adult-use and medical markets.
Adastra Holdings Ltd. (XTRX) opened trading at C$0.92 per share.
